Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Maternal health after Ebola: unmet needs and barriers to healthcare in rural Sierra Leone.

Elston JWT, Danis K, Gray N, West K, Lokuge K, Black B, Stringer B, Jimmisa AS, Biankoe A, Sanko MO, Kazungu DS, Sang S, Loof A, Stephan C, Caleo G.

Health Policy Plan. 2019 Nov 7. pii: czz102. doi: 10.1093/heapol/czz102. [Epub ahead of print]

PMID:
31697378
2.

Simultaneous Targeting of DNA Replication and Homologous Recombination in Glioblastoma with a Polyether Ionophore.

Lim YC, Ensbey KS, Offenhäuser C, D'Souza RCJ, Cullen JK, Stringer BW, Quek H, Bruce ZC, Kijas A, Cianfanelli V, Mahboubi B, Smith F, Jeffree RL, Wiesmüeller L, Wiegmans AP, Bain A, Lombard FJ, Roberts TL, Khanna KK, Lavin MF, Baek K, Hamerlik P, Johns TG, Coster MJ, Boyd AW, Day BW.

Neuro Oncol. 2019 Aug 30. pii: noz159. doi: 10.1093/neuonc/noz159. [Epub ahead of print]

PMID:
31504812
3.

'I treat it but I don't know what this disease is': a qualitative study on noma (cancrum oris) and traditional healing in northwest Nigeria.

Farley E, Bala HM, Lenglet A, Mehta U, Abubakar N, Samuel J, de Jong A, Bil K, Oluyide B, Fotso A, Stringer B, Gil Cuesta J, Venables E.

Int Health. 2019 Aug 24. pii: ihz066. doi: 10.1093/inthealth/ihz066. [Epub ahead of print]

PMID:
31504549
4.

Case of Anthracycline-induced Cardiogenic Shock: A Call to Optimize Modifiable Cardiac Risk Factors Prior to Chemotherapy.

Gabriel A, Stringer B, Hadfield MJ, Madady M.

Cureus. 2019 Jun 20;11(6):e4961. doi: 10.7759/cureus.4961.

5.

The dystroglycan receptor maintains glioma stem cells in the vascular niche.

Day BW, Lathia JD, Bruce ZC, D'Souza RCJ, Baumgartner U, Ensbey KS, Lim YC, Stringer BW, Akgül S, Offenhäuser C, Li Y, Jamieson PR, Smith FM, Jurd CLR, Robertson T, Inglis PL, Lwin Z, Jeffree RL, Johns TG, Bhat KPL, Rich JN, Campbell KP, Boyd AW.

Acta Neuropathol. 2019 Dec;138(6):1033-1052. doi: 10.1007/s00401-019-02069-x. Epub 2019 Aug 28.

PMID:
31463571
6.

Barriers and facilitators to employment in borderline personality disorder: A qualitative study among patients, mental health practitioners and insurance physicians.

Juurlink TT, Vukadin M, Stringer B, Westerman MJ, Lamers F, Anema JR, Beekman ATF, van Marle HJF.

PLoS One. 2019 Jul 23;14(7):e0220233. doi: 10.1371/journal.pone.0220233. eCollection 2019.

7.

'Working to stay healthy', health-seeking behaviour in Bangladesh's urban slums: a qualitative study.

van der Heijden J, Gray N, Stringer B, Rahman A, Akhter S, Kalon S, Dada M, Biswas A.

BMC Public Health. 2019 May 17;19(1):600. doi: 10.1186/s12889-019-6750-0.

8.

A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma.

Stringer BW, Day BW, D'Souza RCJ, Jamieson PR, Ensbey KS, Bruce ZC, Lim YC, Goasdoué K, Offenhäuser C, Akgül S, Allan S, Robertson T, Lucas P, Tollesson G, Campbell S, Winter C, Do H, Dobrovic A, Inglis PL, Jeffree RL, Johns TG, Boyd AW.

Sci Rep. 2019 Mar 20;9(1):4902. doi: 10.1038/s41598-019-41277-z.

9.

Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas.

Ostrovskaya A, Hick C, Hutchinson DS, Stringer BW, Wookey PJ, Wootten D, Sexton PM, Furness SGB.

BMC Cancer. 2019 Feb 18;19(1):157. doi: 10.1186/s12885-019-5369-y.

10.

Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma.

Akgül S, Patch AM, D'Souza RCJ, Mukhopadhyay P, Nones K, Kempe S, Kazakoff SH, Jeffree RL, Stringer BW, Pearson JV, Waddell N, Day BW.

Cancers (Basel). 2019 Feb 6;11(2). pii: E190. doi: 10.3390/cancers11020190.

11.

Controlled light-induced gas phase nitric oxide release from S-nitrosothiol-doped silicone rubber films.

Lautner G, Stringer B, Brisbois EJ, Meyerhoff ME, Schwendeman SP.

Nitric Oxide. 2019 May 1;86:31-37. doi: 10.1016/j.niox.2019.01.016. Epub 2019 Feb 5.

PMID:
30735785
12.

Simple and powerful: a consultant and governance-led bereavement service.

Grimes CE, Stringer B, Roberts-Jones L.

BMJ Support Palliat Care. 2019 Jan 10. pii: bmjspcare-2018-001661. doi: 10.1136/bmjspcare-2018-001661. [Epub ahead of print]

PMID:
30665881
13.

Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models.

Schreiber AR, Nguyen A, Bagby SM, Arcaroli JJ, Yacob BW, Quackenbush K, Guy JL, Crowell T, Stringer B, Danaee H, Kalebic T, Messersmith WA, Pitts TM.

Clin Cancer Drugs. 2018;5(1):42-49. doi: 10.2174/2212697X05666180516120907.

14.

Novel dual-action prodrug triggers apoptosis in glioblastoma cells by releasing a glutathione quencher and lysine-specific histone demethylase 1A inhibitor.

Engel M, Gee YS, Cross D, Maccarone A, Heng B, Hulme A, Smith G, Guillemin GJ, Stringer BW, Hyland CJT, Ooi L.

J Neurochem. 2019 May;149(4):535-550. doi: 10.1111/jnc.14655. Epub 2019 Feb 3.

15.

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma.

Offenhäuser C, Al-Ejeh F, Puttick S, Ensbey KS, Bruce ZC, Jamieson PR, Smith FM, Stringer BW, Carrington B, Fuchs AV, Bell CA, Jeffree R, Rose S, Thurecht KJ, Boyd AW, Day BW.

Cancers (Basel). 2018 Dec 17;10(12). pii: E519. doi: 10.3390/cancers10120519.

16.

Tuning the electrochemiluminescent properties of iridium complexes of N-heterocyclic carbene ligands.

Quan LM, Stringer BD, Haghighatbin MA, Agugiaro J, Barbante GJ, Wilson DJD, Hogan CF, Barnard PJ.

Dalton Trans. 2019 Jan 2;48(2):653-663. doi: 10.1039/c8dt04433c.

PMID:
30542690
17.

Tropomyosin Tpm 2.1 loss induces glioblastoma spreading in soft brain-like environments.

Mitchell CB, Black B, Sun F, Chrzanowski W, Cooper-White J, Maisonneuve B, Stringer B, Day B, Biro M, O'Neill GM.

J Neurooncol. 2019 Jan;141(2):303-313. doi: 10.1007/s11060-018-03049-z. Epub 2018 Dec 9.

PMID:
30535593
18.

Access to palliative care for homeless people: complex lives, complex care.

de Veer AJE, Stringer B, van Meijel B, Verkaik R, Francke AL.

BMC Palliat Care. 2018 Oct 24;17(1):119. doi: 10.1186/s12904-018-0368-3.

19.

Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways.

Hallal S, Mallawaaratchy DM, Wei H, Ebrahimkhani S, Stringer BW, Day BW, Boyd AW, Guillemin GJ, Buckland ME, Kaufman KL.

Mol Neurobiol. 2019 Jun;56(6):4566-4581. doi: 10.1007/s12035-018-1385-1. Epub 2018 Oct 23.

20.

Unusually Strong Electrochemiluminescence from Iridium-Based Redox Polymers Immobilized As Thin Layers or Polymer Nanoparticles.

Carrara S, Stringer B, Shokouhi A, Ramkissoon P, Agugiaro J, Wilson DJD, Barnard PJ, Hogan CF.

ACS Appl Mater Interfaces. 2018 Oct 31;10(43):37251-37257. doi: 10.1021/acsami.8b12995. Epub 2018 Oct 16.

PMID:
30278121
21.

Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma.

Neubauer HA, Tea MN, Zebol JR, Gliddon BL, Stefanidis C, Moretti PAB, Pitman MR, Costabile M, Kular J, Stringer BW, Day BW, Samuel MS, Bonder CS, Powell JA, Pitson SM.

Oncogene. 2019 Feb;38(8):1151-1165. doi: 10.1038/s41388-018-0504-9. Epub 2018 Sep 24.

22.

Changes in cell morphology guide identification of tubulin as the off-target for protein kinase inhibitors.

Hoque M, Abbassi RH, Froio D, Man J, Johns TG, Stringer BW, Day BW, Pajic M, Kassiou M, Munoz L.

Pharmacol Res. 2018 Aug;134:166-178. doi: 10.1016/j.phrs.2018.06.023. Epub 2018 Jun 23.

PMID:
29944980
23.

'When Ebola enters a home, a family, a community': A qualitative study of population perspectives on Ebola control measures in rural and urban areas of Sierra Leone.

Gray N, Stringer B, Bark G, Heller Perache A, Jephcott F, Broeder R, Kremer R, Jimissa AS, Samba TT.

PLoS Negl Trop Dis. 2018 Jun 8;12(6):e0006461. doi: 10.1371/journal.pntd.0006461. eCollection 2018 Jun.

24.

Care provider allocation on admissions to acute mental health wards: The development and validation of the Admission Team Score List.

van den Berg SRN, Stringer B, van de Sande R, Draisma S.

Int J Ment Health Nurs. 2019 Feb;28(1):86-95. doi: 10.1111/inm.12476. Epub 2018 May 18.

PMID:
29777566
25.

A unique 19F MRI agent for the tracking of non phagocytic cells in vivo.

Moonshi SS, Zhang C, Peng H, Puttick S, Rose S, Fisk NM, Bhakoo K, Stringer BW, Qiao GG, Gurr PA, Whittaker AK.

Nanoscale. 2018 May 3;10(17):8226-8239. doi: 10.1039/c8nr00703a.

PMID:
29682654
26.

Anthropology in public health emergencies: what is anthropology good for?

Stellmach D, Beshar I, Bedford J, du Cros P, Stringer B.

BMJ Glob Health. 2018 Mar 25;3(2):e000534. doi: 10.1136/bmjgh-2017-000534. eCollection 2018. Review.

27.

Evaluation of an interaction-skills training for reducing the burden of family caregivers of patients with severe mental illness: a pre-posttest design.

Gharavi Y, Stringer B, Hoogendoorn A, Boogaarts J, Van Raaij B, Van Meijel B.

BMC Psychiatry. 2018 Mar 27;18(1):84. doi: 10.1186/s12888-018-1669-z.

28.

The factors affecting household transmission dynamics and community compliance with Ebola control measures: a mixed-methods study in a rural village in Sierra Leone.

Caleo G, Duncombe J, Jephcott F, Lokuge K, Mills C, Looijen E, Theoharaki F, Kremer R, Kleijer K, Squire J, Lamin M, Stringer B, Weiss HA, Culli D, Di Tanna GL, Greig J.

BMC Public Health. 2018 Feb 13;18(1):248. doi: 10.1186/s12889-018-5158-6.

29.

A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.

Gallery M, Zhang J, Bradley DP, Brauer P, Cvet D, Estevam J, Danaee H, Greenfield E, Li P, Manfredi M, Loke HK, Rabino C, Stringer B, Williamson M, Wyant T, Yang J, Zhu Q, Abu-Yousif A, Veiby OP.

PLoS One. 2018 Jan 25;13(1):e0191046. doi: 10.1371/journal.pone.0191046. eCollection 2018.

30.

A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment.

Hyer ML, Milhollen MA, Ciavarri J, Fleming P, Traore T, Sappal D, Huck J, Shi J, Gavin J, Brownell J, Yang Y, Stringer B, Griffin R, Bruzzese F, Soucy T, Duffy J, Rabino C, Riceberg J, Hoar K, Lublinsky A, Menon S, Sintchak M, Bump N, Pulukuri SM, Langston S, Tirrell S, Kuranda M, Veiby P, Newcomb J, Li P, Wu JT, Powe J, Dick LR, Greenspan P, Galvin K, Manfredi M, Claiborne C, Amidon BS, Bence NF.

Nat Med. 2018 Feb;24(2):186-193. doi: 10.1038/nm.4474. Epub 2018 Jan 15.

PMID:
29334375
31.

Systematically linking tranSMART, Galaxy and EGA for reusing human translational research data.

Zhang C, Bijlard J, Staiger C, Scollen S, van Enckevort D, Hoogstrate Y, Senf A, Hiltemann S, Repo S, Pipping W, Bierkens M, Payralbe S, Stringer B, Heringa J, Stubbs A, Bonino Da Silva Santos LO, Belien J, Weistra W, Azevedo R, van Bochove K, Meijer G, Boiten JW, Rambla J, Fijneman R, Spalding JD, Abeln S.

F1000Res. 2017 Aug 16;6. pii: ELIXIR-1488. doi: 10.12688/f1000research.12168.1. eCollection 2017.

32.

Dual-wavelength reflectance spectroscopy of the superior vena cava: A method for placing central venous catheters at the cavoatrial junction.

Stringer BJ, Shumway SB, Holbrook MD, Copeland CG, Gosch AA, Kück K.

J Biophotonics. 2018 Apr;11(4):e201700018. doi: 10.1002/jbio.201700018. Epub 2017 Dec 12.

PMID:
28772008
33.

Diabetes care in a complex humanitarian emergency setting: a qualitative evaluation.

Murphy A, Biringanine M, Roberts B, Stringer B, Perel P, Jobanputra K.

BMC Health Serv Res. 2017 Jun 23;17(1):431. doi: 10.1186/s12913-017-2362-5.

34.

Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma.

Greenall SA, Lim YC, Mitchell CB, Ensbey KS, Stringer BW, Wilding AL, O'Neill GM, McDonald KL, Gough DJ, Day BW, Johns TG.

Oncogenesis. 2017 May 15;6(5):e336. doi: 10.1038/oncsis.2017.33.

35.

Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma.

Gilabert-Oriol R, Furness SGB, Stringer BW, Weng A, Fuchs H, Day BW, Kourakis A, Boyd AW, Hare DL, Thakur M, Johns TG, Wookey PJ.

Cancer Immunol Immunother. 2017 Sep;66(9):1217-1228. doi: 10.1007/s00262-017-2013-z. Epub 2017 May 13.

PMID:
28501939
36.

Development and Biological Evaluation of a Photoactivatable Small Molecule Microtubule-Targeting Agent.

Döbber A, Phoa AF, Abbassi RH, Stringer BW, Day BW, Johns TG, Abadleh M, Peifer C, Munoz L.

ACS Med Chem Lett. 2017 Mar 15;8(4):395-400. doi: 10.1021/acsmedchemlett.6b00483. eCollection 2017 Apr 13.

37.

[Prescribing psychotropic medication by the nurse practitioner in mental health care: an explorative study].

Rookhuizen ED, Stringer B, Huising MS, de Ruijter E, van Meijel B.

Tijdschr Psychiatr. 2017;59(4):229-233. Dutch.

38.

Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma.

Zhou Q, Phoa AF, Abbassi RH, Hoque M, Reekie TA, Font JS, Ryan RM, Stringer BW, Day BW, Johns TG, Munoz L, Kassiou M.

J Med Chem. 2017 Mar 9;60(5):2052-2070. doi: 10.1021/acs.jmedchem.6b01840. Epub 2017 Feb 28.

PMID:
28206758
39.

Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.

Tivnan A, Heilinger T, Ramsey JM, O'Connor G, Pokorny JL, Sarkaria JN, Stringer BW, Day BW, Boyd AW, Kim EL, Lode HN, Cryan SA, Prehn JH.

Oncotarget. 2017 Mar 7;8(10):16605-16620. doi: 10.18632/oncotarget.15073.

40.

"Life is so easy on ART, once you accept it": Acceptance, denial and linkage to HIV care in Shiselweni, Swaziland.

Horter S, Thabede Z, Dlamini V, Bernays S, Stringer B, Mazibuko S, Dube L, Rusch B, Jobanputra K.

Soc Sci Med. 2017 Mar;176:52-59. doi: 10.1016/j.socscimed.2017.01.006. Epub 2017 Jan 6.

41.

EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.

Charmsaz S, Al-Ejeh F, Yeadon TM, Miller KJ, Smith FM, Stringer BW, Moore AS, Lee FT, Cooper LT, Stylianou C, Yarranton GT, Woronicz J, Scott AM, Lackmann M, Boyd AW.

Leukemia. 2017 Aug;31(8):1779-1787. doi: 10.1038/leu.2016.371. Epub 2016 Dec 6.

PMID:
27922598
42.

Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.

Horter S, Stringer B, Greig J, Amangeldiev A, Tillashaikhov MN, Parpieva N, Tigay Z, du Cros P.

BMC Infect Dis. 2016 Jul 28;16:362. doi: 10.1186/s12879-016-1723-8.

43.

'They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan.

Stringer B, Lowton K, Tillashaikhov M, Parpieva N, Ulmasova D, du Cros P, Hasker E, Sergeeva N.

Int J Tuberc Lung Dis. 2016 Aug;20(8):1084-90. doi: 10.5588/ijtld.15.0815.

PMID:
27393544
44.

Systematic review of self-management in patients with schizophrenia: psychometric assessment of tools, levels of self-management and associated factors.

van Schie D, Castelein S, van der Bijl J, Meijburg R, Stringer B, van Meijel B.

J Adv Nurs. 2016 Nov;72(11):2598-2611. doi: 10.1111/jan.13023. Epub 2016 Jun 13. Review.

PMID:
27200500
45.

Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma.

Stringer BW, Bunt J, Day BW, Barry G, Jamieson PR, Ensbey KS, Bruce ZC, Goasdoué K, Vidal H, Charmsaz S, Smith FM, Cooper LT, Piper M, Boyd AW, Richards LJ.

Oncotarget. 2016 May 17;7(20):29306-20. doi: 10.18632/oncotarget.8720.

46.

Differential response of patient-derived primary glioblastoma cells to environmental stiffness.

Grundy TJ, De Leon E, Griffin KR, Stringer BW, Day BW, Fabry B, Cooper-White J, O'Neill GM.

Sci Rep. 2016 Mar 21;6:23353. doi: 10.1038/srep23353.

47.

KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.

Chattopadhyay N, Berger AJ, Koenig E, Bannerman B, Garnsey J, Bernard H, Hales P, Maldonado Lopez A, Yang Y, Donelan J, Jordan K, Tirrell S, Stringer B, Xia C, Hather G, Galvin K, Manfredi M, Rhodes N, Amidon B.

PLoS One. 2015 Dec 28;10(12):e0144825. doi: 10.1371/journal.pone.0144825. eCollection 2015.

48.

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.

Zakaria Z, Tivnan A, Flanagan L, Murray DW, Salvucci M, Stringer BW, Day BW, Boyd AW, Kögel D, Rehm M, O'Brien DF, Byrne AT, Prehn JH.

Br J Cancer. 2016 Jan 19;114(2):188-98. doi: 10.1038/bjc.2015.420. Epub 2015 Dec 10.

49.

Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling.

Phoa AF, Browne S, Gurgis FM, Åkerfeldt MC, Döbber A, Renn C, Peifer C, Stringer BW, Day BW, Wong C, Chircop M, Johns TG, Kassiou M, Munoz L.

Biochem Pharmacol. 2015 Dec 15;98(4):587-601. doi: 10.1016/j.bcp.2015.10.014. Epub 2015 Oct 28.

PMID:
26519552
50.

Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method.

Rundle-Thiele D, Day B, Stringer B, Fay M, Martin J, Jeffree RL, Thomas P, Bell C, Salvado O, Gal Y, Coulthard A, Crozier S, Rose S.

J Med Radiat Sci. 2015 Jun;62(2):92-8. doi: 10.1002/jmrs.103. Epub 2015 Apr 16.

Supplemental Content

Loading ...
Support Center